CONVERGENCE
University of Pittsburgh Office of the Senior Vice Chancellor for Research 2022-23 Annual Report
Pitt Number Three in NIH funding
The National Institutes of Health (NIH)—the nation’s medical research and development agency—has been a major supporter of academic medical scientists throughout the United States.
In 2023, the University of Pittsburgh was announced as the third-highest recipient of funding from the NIH, improving from a rank of 11th in the previous year. The $675 million in NIH funding Pitt received puts it behind only Johns Hopkins University and the University of California, San Francisco.
Pitt’s School of Medicine is responsible for pulling in a substantial portion of these funds—78% of the grand total. “The last two years’ major increases are thanks to the innovation and dedication of our Pitt Medicine faculty and staff,” says Anantha Shekhar, Pitt’s senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of the School of Medicine. “We’re further cementing our place among the top academic medical institutions in the country.”
In many ways, the rise in rankings can be attributed to the shape of the grants Pitt has been receiving from NIH. Pitt proposes—and wins—bigger, team-oriented awards. Grants of $5-10 million have nearly doubled. Researchers at Pitt are doing more … together.
Anantha Shekhar
University of Pittsburgh ranks third in NIH funding, placing it within a cohort of very prestigious institutions. The ranking list is compiled and announced by the Blue Ridge Institute for Medical Research. This ranking is based on the NIH funding report made available through the NIH RePORTER. The latest ranking available corresponds to Federal Fiscal Year 2022.
Source: Blue Ridge Institute for Medical Research (BRIMR)
